413 related articles for article (PubMed ID: 33220521)
41. [Therapeutic options for autoimmune encephalomyelitis].
Borisow N; Prüss H; Paul F
Nervenarzt; 2013 Apr; 84(4):461-5. PubMed ID: 23568167
[TBL] [Abstract][Full Text] [Related]
42. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.
Iorio R; Damato V; Evoli A; Gessi M; Gaudino S; Di Lazzaro V; Spagni G; Sluijs JA; Hol EM
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):138-146. PubMed ID: 28951498
[TBL] [Abstract][Full Text] [Related]
43. Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity.
Casado JL; Gil-Peralta A; Graus F; Arenas C; Lopez JM; Alberca R
Neurology; 1994 Aug; 44(8):1521-2. PubMed ID: 8058163
[TBL] [Abstract][Full Text] [Related]
44. [Progressive encephalomyelitis with rigidity. Clinical and electrophysiological aspects].
Gazulla Abío J; Benavente Aguilar I; Capablo Liesa JL
Neurologia; 2001 Feb; 16(2):85-8. PubMed ID: 11257936
[TBL] [Abstract][Full Text] [Related]
45. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.
Ali F; Wijdicks EF
Neurocrit Care; 2020 Feb; 32(1):286-294. PubMed ID: 31732848
[TBL] [Abstract][Full Text] [Related]
46. Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's disease.
Bonelli RM; Niederwieser G; Diez J; Gruber A; Költringer P
Clin Neuropharmacol; 2002; 25(1):58-60. PubMed ID: 11852299
[TBL] [Abstract][Full Text] [Related]
47. [What helps in the treatment of restless legs?].
Mühlau G
MMW Fortschr Med; 2004 Nov; 146(46):49. PubMed ID: 15600046
[No Abstract] [Full Text] [Related]
48. A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon.
Degeneffe A; Dagonnier M; D'hondt A; Elosegi JA
BMC Neurol; 2018 Oct; 18(1):173. PubMed ID: 30336789
[TBL] [Abstract][Full Text] [Related]
49. Inspiratory laryngeal stridor as the main feature of progressive encephalomyelitis with rigidity and myoclonus: a case report and literature review.
Yao Q; Fu M; Ren L; Lin C; Cao L
BMC Neurol; 2022 Jan; 22(1):42. PubMed ID: 35090404
[TBL] [Abstract][Full Text] [Related]
50. A fatal case of glycine receptor antibody-mediated autoimmune encephalitis.
Reniers W; Ernon L; Bekelaar K
Acta Neurol Belg; 2021 Feb; 121(1):269-270. PubMed ID: 33449270
[No Abstract] [Full Text] [Related]
51. [Six months treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice].
Mühlau G
MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):87-93. PubMed ID: 15662897
[TBL] [Abstract][Full Text] [Related]
52. Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys.
Hadj Tahar A; Ekesbo A; Grégoire L; Bangassoro E; Svensson KA; Tedroff J; Bédard PJ
Eur J Pharmacol; 2001 Feb; 412(3):247-54. PubMed ID: 11166288
[TBL] [Abstract][Full Text] [Related]
53. Hypoventilation in glycine-receptor antibody related progressive encephalomyelitis, rigidity and myoclonus.
Bourke D; Roxburgh R; Vincent A; Cleland J; Jeffery O; Dugan N; Abernethy D; King A; Anderson N
J Clin Neurosci; 2014 May; 21(5):876-8. PubMed ID: 24411327
[TBL] [Abstract][Full Text] [Related]
54. Sustained-release formulation of levodopa methyl ester/benserazide for prolonged suppressing dyskinesia expression in 6-OHDA-leisoned rats.
Ren T; Yang X; Wu N; Cai Y; Liu Z; Yuan W
Neurosci Lett; 2011 Sep; 502(2):117-22. PubMed ID: 21835223
[TBL] [Abstract][Full Text] [Related]
55. Progressive encephalomyelitis with rigidity and myoclonus: a pediatric case report and literature review.
Li Y; Wang JW; Chen QH; Wu RH; Luo XY; He ZW
BMC Pediatr; 2024 Jul; 24(1):427. PubMed ID: 38961420
[TBL] [Abstract][Full Text] [Related]
56. [Influence of L-DOPA on rat brain depending on individual behavioral features].
Sergutina AV; Gershteĭn LM
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):56-9. PubMed ID: 15849866
[TBL] [Abstract][Full Text] [Related]
57. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
Huang L; Deng M; Zhang S; Fang Y; Li L
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
[TBL] [Abstract][Full Text] [Related]
58. Progressive encephalomyelitis with rigidity associated with anti-amphiphysin antibodies.
Ishii A; Hayashi A; Ohkoshi N; Matsuno S; Shoji S
J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):661-2. PubMed ID: 15026525
[No Abstract] [Full Text] [Related]
59. Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.
Yang X; Chen Y; Hong X; Wu N; Song L; Yuan W; Liu Z
Drug Des Devel Ther; 2012; 6():341-7. PubMed ID: 23185117
[TBL] [Abstract][Full Text] [Related]
60. Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome.
Espay AJ; Chen R
Muscle Nerve; 2006 Dec; 34(6):677-90. PubMed ID: 16969837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
